This Design validation 4 hour session will discuss how to write validation protocol and determine acceptance criteria. It will also explain the systematic approach to validate analytical procedures.
Quality measures are tools that help us measure or quantify healthcare processes, outcomes, patient perceptions, and organizational structure and/or systems that are associated with the ability to provide high-quality health care and/or that relate to one or more quality goals for health care.
This presentation discusses quality metrics and how the pharmaceutical industry uses metrics. It defines quality metrics as elements that evaluate processes like customer satisfaction and defects. Metrics can help improve quality and productivity. The FDA requires metrics to evaluate manufacturing quality and reduce drug shortages. Guidelines like ICH Q8-Q11 provide a framework for using metrics flexibly to focus on quality. Leading and lagging metrics are discussed.
Cosmetic products animal testing in the EU - legislationTadej Feregotto
This presentation explains the rules and legislation regarding animal testing of cosmetic products in the EU and its development over the last few years.
Trust, but Verify - Tips & Tools for FSMA's Foreign Supplier VerificationTraceGains
The FDA’s Food Safety Modernization Act (FSMA) rule on Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals is now final, and compliance dates for some businesses begin in 18 months. To help the food supply chain prepare, TraceGains’ will zero-in on the FSVP in its upcoming webinar: “Trust, but Verify – Tips and Tools for Foreign Supplier Verification (FSV).”
TraceGains will host FDA attorney Marc Sanchez as its guest speaker for the webinar. The session is designed to give an overview of the key provisions and tips and tools you can use to simplify compliance with the new requirements and establish a world-class FSVP.
Specifically, the webinar will cover:
Examining your current supplier program and how to identify gaps in hazard analysis;
What the FDA says about electronic record-keeping for FSV;
What involvement is expected from the executive and management level;
Third-party verification of foreign suppliers;
Risk management best practices for FSV; and,
Tips & tools to simplify compliance with FSV.
"Quality Metrics" not only helpful US FDA, moreover helpful for all pharmaceutical industries.
Quality metrics are helpful for Chairman, MD, CEO & higher management to evaluate & know the firm performance (*Indirectly different department employees performance & productivity).
The document discusses quality metrics that are used in the pharmaceutical industry to monitor quality control systems and processes. It defines three key quality metrics that the FDA intends to calculate: (1) Lot Acceptance Rate (LAR), which measures the number of accepted lots versus total lots started; (2) Invalidated Out-of-Specification Rate (IOOSR), which measures invalidated out-of-specification test results versus total out-of-specification results; and (3) Product Quality Complaint Rate (PQCR), which measures the number of quality complaints received versus total units distributed. Quality metrics are important to ensure acceptable product quality and assess performance and improvements.
This presentation talks about the cosmetics good manufacturing practice (GMP) and standard ISO 22716, which cosmetic manufacturers have to follow if they want to put their products on the EU market.
Quality measures are tools that help us measure or quantify healthcare processes, outcomes, patient perceptions, and organizational structure and/or systems that are associated with the ability to provide high-quality health care and/or that relate to one or more quality goals for health care.
This presentation discusses quality metrics and how the pharmaceutical industry uses metrics. It defines quality metrics as elements that evaluate processes like customer satisfaction and defects. Metrics can help improve quality and productivity. The FDA requires metrics to evaluate manufacturing quality and reduce drug shortages. Guidelines like ICH Q8-Q11 provide a framework for using metrics flexibly to focus on quality. Leading and lagging metrics are discussed.
Cosmetic products animal testing in the EU - legislationTadej Feregotto
This presentation explains the rules and legislation regarding animal testing of cosmetic products in the EU and its development over the last few years.
Trust, but Verify - Tips & Tools for FSMA's Foreign Supplier VerificationTraceGains
The FDA’s Food Safety Modernization Act (FSMA) rule on Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals is now final, and compliance dates for some businesses begin in 18 months. To help the food supply chain prepare, TraceGains’ will zero-in on the FSVP in its upcoming webinar: “Trust, but Verify – Tips and Tools for Foreign Supplier Verification (FSV).”
TraceGains will host FDA attorney Marc Sanchez as its guest speaker for the webinar. The session is designed to give an overview of the key provisions and tips and tools you can use to simplify compliance with the new requirements and establish a world-class FSVP.
Specifically, the webinar will cover:
Examining your current supplier program and how to identify gaps in hazard analysis;
What the FDA says about electronic record-keeping for FSV;
What involvement is expected from the executive and management level;
Third-party verification of foreign suppliers;
Risk management best practices for FSV; and,
Tips & tools to simplify compliance with FSV.
"Quality Metrics" not only helpful US FDA, moreover helpful for all pharmaceutical industries.
Quality metrics are helpful for Chairman, MD, CEO & higher management to evaluate & know the firm performance (*Indirectly different department employees performance & productivity).
The document discusses quality metrics that are used in the pharmaceutical industry to monitor quality control systems and processes. It defines three key quality metrics that the FDA intends to calculate: (1) Lot Acceptance Rate (LAR), which measures the number of accepted lots versus total lots started; (2) Invalidated Out-of-Specification Rate (IOOSR), which measures invalidated out-of-specification test results versus total out-of-specification results; and (3) Product Quality Complaint Rate (PQCR), which measures the number of quality complaints received versus total units distributed. Quality metrics are important to ensure acceptable product quality and assess performance and improvements.
This presentation talks about the cosmetics good manufacturing practice (GMP) and standard ISO 22716, which cosmetic manufacturers have to follow if they want to put their products on the EU market.
This document discusses granulation processes and quality management in the pharmaceutical industry. It covers topics like cGMP, SUPAC guidelines for post-approval changes, validation of granulation equipment and processes, and questionnaires for auditing granulation. The key points are that granulation is a critical manufacturing step that must be validated; SUPAC provides guidance on composition, batch size, site and equipment changes; and validation involves qualifying equipment and demonstrating consistent product quality through processes.
This presentation discusses the revision of the FDA's Question-based Review (QbR) system for generic drug submissions. The QbR questions were revised to fully incorporate quality-by-design (QbD) elements like quality target product profiles and critical quality attributes. Key changes include removing questions answered with 'refer to DMF' and revising 'yes/no' questions. The revised QbR aims to facilitate a more science- and risk-based review of generic drug applications and further encourage QbD principles. A mock application and FAQ are in development to aid understanding of the new QbR. Feedback on the revised questions is welcome.
What is good manufacturing practice gmp certificate and what is a benefits of...Rishabhparihar8
GMP Certification is of immense importance in the supplement industry as it is today, but it can be a long and expensive process, especially if you are entering the industry.
*If You have any doubt feel free to contact Corpseed Pvt.*
This document provides an introduction and overview of a training session on Good Manufacturing Practices (GMP) for the 21st century. It notes that the presentation will reflect the presenter's views and is not meant to represent any official policies. Examples of recent drug contamination and mix-ups are presented to illustrate the importance of GMP in ensuring consistent quality, preventing contamination and mix-ups. GMP is described as a set of regulatory methods to inspect manufacturing practices to protect the integrity and quality of products intended for human use and ensure they are consistently produced and controlled.
NABL provides accreditation to laboratories in India based on international standards like ISO 15189 and ISO 17025. It ensures laboratories are properly qualified and provides benefits like increased confidence in test reports and worldwide acceptance. The accreditation process involves an application, document review, assessment of the laboratory's management system and technical competence, and surveillance after accreditation is granted. If qualified, NABL issues an accreditation certificate valid for two years.
GVK Biosciences (GVK BIO) Clinical Research division has an independent Quality Assurance (QA) unit which conducts audits of services of all business lines within the division on a routine basis to ensure delivery of quality services. The Clinical Research QA staff report
to the Director-QA, GVK BIO who in turn reports to the CEO of GVK BIO
Participate in the full, interactive on-demand webinar here: https://bit.ly/ProcessValWebinar
Process validation is a complex step in the transition to commercial scale manufacturing. While Quality By Design (QBD) is the standard option for a risk-mitigating process validation strategy, there are other options for more flexibility and speed. Join our webinar to learn how outsourcing to a CDMO, able to take an adaptive, risk-based validation approach, will accelerate your time to market.
In this webinar, you will discover more about:
• How outsourcing to a CDMO partner in late-stage will increase flexibility and speed
• How a risk-based approach can help you optimize your process validation strategy
• How we have implemented a risk-based approach for our clients via case studies
From unannounced audits to food fraud, what changes are in store for SQF in 2016? TraceGains hosted LeAnn Chuboff, Senior Technical Director of the Safe Quality Food Institute on March 9th, 2016 for a webinar to learn about proposed changes to the SQF Code and insights gleaned from the latest GFSI guidance to be released in early March 2016.
The webinar gave attendees a sneak peek into the proposed changes for SQF Edition 8 and other program improvements. Specifically, the SQF webinar covered:
-SQF Edition 8 implementation timeline
-Lessons learned from recalls and withdrawals
-Unannounced audit findings
-Improving auditor consistency & competency
-Incorporating FSMA and other international laws & regulations
-How food defense will be further elevated in 2016
The document discusses control strategies for pharmaceutical manufacturing processes as outlined in ICH Q7 and Q11 guidelines. It notes that control strategies should be based on current product and process understanding to ensure quality and performance. Traditionally, control strategies focused on set points and operating ranges, but an enhanced approach calls for more systematic identification of variability sources, increased process understanding, and flexibility in operating parameters. The document also assigns a 10-hour take-home assignment analyzing control strategies and case studies of API manufacturing failures.
The document discusses the International Conference on Harmonization (ICH). ICH was established in 1990 to harmonize technical requirements for pharmaceutical registration among countries in Europe, Japan and the United States. It aims to ensure safety, quality and efficacy of drugs while avoiding duplication of testing. Key ICH guidelines cover quality, safety, efficacy and multidisciplinary topics. Stability testing guidelines require evaluating drug products under different storage conditions and timepoints to determine shelf life. The harmonization process has led to over 50 guidelines streamlining pharmaceutical research and development globally.
This document provides an overview of post-marketing surveillance requirements for drug products. It discusses general reporting requirements including field alert reports, annual reports, labeling changes, and adverse event reporting. The key aspects of post-marketing surveillance are monitoring adverse drug reactions, ensuring compliance with manufacturing standards, and completing any agreed upon Phase IV clinical studies. Maintaining vigilance during post-marketing surveillance is important to discover new safety risks and provide additional information on a drug's benefits and risks.
Introduction of training on pharmaceutical quality system Dr.Milind Pathak
The document provides information about a training on pharmaceutical quality systems organized by Quality Circle Forum of India (QCFI). QCFI is a non-profit organization that provides training to professionals at different levels in industries. The Ankleshwar chapter of QCFI has launched activities like 6-month evening coaching and campus training programs on pharmaceutical quality systems and regulatory guidelines for pharmaceutical industries. The training modules will cover topics like cGMP, documentation, sanitation, validations, quality risk management and ICH guidelines. The training will be participatory in nature followed by an evaluation test, and certificates will be distributed. It will be conducted by Dr. Milind Pathak, who has 29 years of experience in quality assurance, quality systems and
Good Manufacturing Practice, or GMP, is a set of practices and systems that are aimed at making sure that pharmaceutical products are manufactured in conformance with set requirements and standards. The aim of GMP also referred to sometimes as cGMP or Current Good Manufacturing Practice, is to ensure that there is control and consistency in the pharmaceutical products, so that the processes used for controlling quality and consistency of the product can be traced back in the event of a problem.
Overview And Principles Of Standardization 27 May 2008anisazila
This document provides an overview of standardization and conformity assessment. It defines what standards and specifications are, and describes the different categories and levels of standards from international to national to industry standards. It explains that standards are developed by committees with representatives from government, industry, consumers and other groups. Standards help ensure quality, safety, interchangeability and fair trade. Conformity assessment is the process of testing and certifying that products meet relevant standards, and accreditation certifies the competence of the conformity assessment bodies. The aims of standardization in construction are to improve quality of life, trade conditions, efficient use of resources and quality of goods and services.
Industry Program In Pharma Quality Assurance And Quality Controlbiinoida
The document describes an industry program in pharmaceutical quality assurance and quality control offered through distance learning. The 12-month program aims to enhance knowledge of quality professionals and provide in-depth training in areas like GMP, quality assurance, regulation, and statistics. Participants can pursue careers in quality assurance, control, engineering, and management and work for major pharmaceutical companies upon completion.
Chill Out About FSMA - It's Complex, but it's Not Rocket ScienceTraceGains
Nervous about FSMA? With such sweeping changes to the food safety landscape, it’s only natural to be a little nervous. Especially when you consider the voluminous pages of regulatory language, several rules are still pending, and FDA's plan to develop and offer training to industry is still unfolding. In response to these challenges, TraceGains has developed a new webinar series on FSMA readiness with FDA attorney Marc Sanchez to help make the tasks ahead a little less daunting.
The webinar “Chill Out about FSMA - It’s Complex, but it’s Not Rocket Science,” is designed to give an overview of FSMA's key provisions and the implementation timeline. Specifically, guest speaker Marc Sanchez will:
Interpret the rules and guidance published FDA on assembling a qualified food safety team;
Discuss how to analyze exiting quality and safety systems and identify gaps; and,
Offer strategies to document training and implementation of a FSMA-compliant food safety plan.
Validation sampling should exceed routine QA sampling based on the impact and risk analysis of the change. The protocol should specify the sampling, such as number of samples, locations, and statistical analysis, based on the risk.
Highway Geometric Design control and criteria-2Muhammad Faisal
This document discusses traffic characteristics that influence highway design, including volume, composition, speed, and projections. It notes that traffic volume indicates the need for improvements and influences design features like lanes and widths. Average daily traffic and peak hour volumes are important metrics. Directionality of traffic must also be considered. Traffic composition, including the number of trucks, affects design due to size and speed differences versus passenger vehicles. Design speed, a selected speed used for geometric design, should fit drivers' expectations and be consistent along a highway. Projecting future traffic over a 20-year period is common for design.
This document discusses granulation processes and quality management in the pharmaceutical industry. It covers topics like cGMP, SUPAC guidelines for post-approval changes, validation of granulation equipment and processes, and questionnaires for auditing granulation. The key points are that granulation is a critical manufacturing step that must be validated; SUPAC provides guidance on composition, batch size, site and equipment changes; and validation involves qualifying equipment and demonstrating consistent product quality through processes.
This presentation discusses the revision of the FDA's Question-based Review (QbR) system for generic drug submissions. The QbR questions were revised to fully incorporate quality-by-design (QbD) elements like quality target product profiles and critical quality attributes. Key changes include removing questions answered with 'refer to DMF' and revising 'yes/no' questions. The revised QbR aims to facilitate a more science- and risk-based review of generic drug applications and further encourage QbD principles. A mock application and FAQ are in development to aid understanding of the new QbR. Feedback on the revised questions is welcome.
What is good manufacturing practice gmp certificate and what is a benefits of...Rishabhparihar8
GMP Certification is of immense importance in the supplement industry as it is today, but it can be a long and expensive process, especially if you are entering the industry.
*If You have any doubt feel free to contact Corpseed Pvt.*
This document provides an introduction and overview of a training session on Good Manufacturing Practices (GMP) for the 21st century. It notes that the presentation will reflect the presenter's views and is not meant to represent any official policies. Examples of recent drug contamination and mix-ups are presented to illustrate the importance of GMP in ensuring consistent quality, preventing contamination and mix-ups. GMP is described as a set of regulatory methods to inspect manufacturing practices to protect the integrity and quality of products intended for human use and ensure they are consistently produced and controlled.
NABL provides accreditation to laboratories in India based on international standards like ISO 15189 and ISO 17025. It ensures laboratories are properly qualified and provides benefits like increased confidence in test reports and worldwide acceptance. The accreditation process involves an application, document review, assessment of the laboratory's management system and technical competence, and surveillance after accreditation is granted. If qualified, NABL issues an accreditation certificate valid for two years.
GVK Biosciences (GVK BIO) Clinical Research division has an independent Quality Assurance (QA) unit which conducts audits of services of all business lines within the division on a routine basis to ensure delivery of quality services. The Clinical Research QA staff report
to the Director-QA, GVK BIO who in turn reports to the CEO of GVK BIO
Participate in the full, interactive on-demand webinar here: https://bit.ly/ProcessValWebinar
Process validation is a complex step in the transition to commercial scale manufacturing. While Quality By Design (QBD) is the standard option for a risk-mitigating process validation strategy, there are other options for more flexibility and speed. Join our webinar to learn how outsourcing to a CDMO, able to take an adaptive, risk-based validation approach, will accelerate your time to market.
In this webinar, you will discover more about:
• How outsourcing to a CDMO partner in late-stage will increase flexibility and speed
• How a risk-based approach can help you optimize your process validation strategy
• How we have implemented a risk-based approach for our clients via case studies
From unannounced audits to food fraud, what changes are in store for SQF in 2016? TraceGains hosted LeAnn Chuboff, Senior Technical Director of the Safe Quality Food Institute on March 9th, 2016 for a webinar to learn about proposed changes to the SQF Code and insights gleaned from the latest GFSI guidance to be released in early March 2016.
The webinar gave attendees a sneak peek into the proposed changes for SQF Edition 8 and other program improvements. Specifically, the SQF webinar covered:
-SQF Edition 8 implementation timeline
-Lessons learned from recalls and withdrawals
-Unannounced audit findings
-Improving auditor consistency & competency
-Incorporating FSMA and other international laws & regulations
-How food defense will be further elevated in 2016
The document discusses control strategies for pharmaceutical manufacturing processes as outlined in ICH Q7 and Q11 guidelines. It notes that control strategies should be based on current product and process understanding to ensure quality and performance. Traditionally, control strategies focused on set points and operating ranges, but an enhanced approach calls for more systematic identification of variability sources, increased process understanding, and flexibility in operating parameters. The document also assigns a 10-hour take-home assignment analyzing control strategies and case studies of API manufacturing failures.
The document discusses the International Conference on Harmonization (ICH). ICH was established in 1990 to harmonize technical requirements for pharmaceutical registration among countries in Europe, Japan and the United States. It aims to ensure safety, quality and efficacy of drugs while avoiding duplication of testing. Key ICH guidelines cover quality, safety, efficacy and multidisciplinary topics. Stability testing guidelines require evaluating drug products under different storage conditions and timepoints to determine shelf life. The harmonization process has led to over 50 guidelines streamlining pharmaceutical research and development globally.
This document provides an overview of post-marketing surveillance requirements for drug products. It discusses general reporting requirements including field alert reports, annual reports, labeling changes, and adverse event reporting. The key aspects of post-marketing surveillance are monitoring adverse drug reactions, ensuring compliance with manufacturing standards, and completing any agreed upon Phase IV clinical studies. Maintaining vigilance during post-marketing surveillance is important to discover new safety risks and provide additional information on a drug's benefits and risks.
Introduction of training on pharmaceutical quality system Dr.Milind Pathak
The document provides information about a training on pharmaceutical quality systems organized by Quality Circle Forum of India (QCFI). QCFI is a non-profit organization that provides training to professionals at different levels in industries. The Ankleshwar chapter of QCFI has launched activities like 6-month evening coaching and campus training programs on pharmaceutical quality systems and regulatory guidelines for pharmaceutical industries. The training modules will cover topics like cGMP, documentation, sanitation, validations, quality risk management and ICH guidelines. The training will be participatory in nature followed by an evaluation test, and certificates will be distributed. It will be conducted by Dr. Milind Pathak, who has 29 years of experience in quality assurance, quality systems and
Good Manufacturing Practice, or GMP, is a set of practices and systems that are aimed at making sure that pharmaceutical products are manufactured in conformance with set requirements and standards. The aim of GMP also referred to sometimes as cGMP or Current Good Manufacturing Practice, is to ensure that there is control and consistency in the pharmaceutical products, so that the processes used for controlling quality and consistency of the product can be traced back in the event of a problem.
Overview And Principles Of Standardization 27 May 2008anisazila
This document provides an overview of standardization and conformity assessment. It defines what standards and specifications are, and describes the different categories and levels of standards from international to national to industry standards. It explains that standards are developed by committees with representatives from government, industry, consumers and other groups. Standards help ensure quality, safety, interchangeability and fair trade. Conformity assessment is the process of testing and certifying that products meet relevant standards, and accreditation certifies the competence of the conformity assessment bodies. The aims of standardization in construction are to improve quality of life, trade conditions, efficient use of resources and quality of goods and services.
Industry Program In Pharma Quality Assurance And Quality Controlbiinoida
The document describes an industry program in pharmaceutical quality assurance and quality control offered through distance learning. The 12-month program aims to enhance knowledge of quality professionals and provide in-depth training in areas like GMP, quality assurance, regulation, and statistics. Participants can pursue careers in quality assurance, control, engineering, and management and work for major pharmaceutical companies upon completion.
Chill Out About FSMA - It's Complex, but it's Not Rocket ScienceTraceGains
Nervous about FSMA? With such sweeping changes to the food safety landscape, it’s only natural to be a little nervous. Especially when you consider the voluminous pages of regulatory language, several rules are still pending, and FDA's plan to develop and offer training to industry is still unfolding. In response to these challenges, TraceGains has developed a new webinar series on FSMA readiness with FDA attorney Marc Sanchez to help make the tasks ahead a little less daunting.
The webinar “Chill Out about FSMA - It’s Complex, but it’s Not Rocket Science,” is designed to give an overview of FSMA's key provisions and the implementation timeline. Specifically, guest speaker Marc Sanchez will:
Interpret the rules and guidance published FDA on assembling a qualified food safety team;
Discuss how to analyze exiting quality and safety systems and identify gaps; and,
Offer strategies to document training and implementation of a FSMA-compliant food safety plan.
Validation sampling should exceed routine QA sampling based on the impact and risk analysis of the change. The protocol should specify the sampling, such as number of samples, locations, and statistical analysis, based on the risk.
Highway Geometric Design control and criteria-2Muhammad Faisal
This document discusses traffic characteristics that influence highway design, including volume, composition, speed, and projections. It notes that traffic volume indicates the need for improvements and influences design features like lanes and widths. Average daily traffic and peak hour volumes are important metrics. Directionality of traffic must also be considered. Traffic composition, including the number of trucks, affects design due to size and speed differences versus passenger vehicles. Design speed, a selected speed used for geometric design, should fit drivers' expectations and be consistent along a highway. Projecting future traffic over a 20-year period is common for design.
The late-stage analytical method lifecycle - Risk-based validation and extens...Stephan O. Krause, PhD
This document outlines an analytical method transfer (AMT) study design for transferring a validated potency method from an original quality control laboratory to another laboratory. The study will evaluate accuracy/matching and intermediate precision between the two laboratories using three potency levels across two operators, two days, and two replicates per condition, for a total of 24 observations per laboratory. Acceptance criteria require the relative difference between mean potency measurements from each lab to be within -10% to +10%, and replicate precision within each lab to be below 6%. The results will demonstrate equivalence between the sending and receiving laboratories.
Crystals have healing energy that can benefit mental, physical, and spiritual well-being when their vibrational frequency amplifies alongside the body's energy. The document recommends starting with citrine to inspire abundance and deflect negative energy, clear quartz to protect against harm and aid ambition, and rose quartz to inspire self-love. Amethyst opens the mind and evades negative energy, while black onyx protects by absorbing negative energy. These are just a few of the crystals that have been used for healing for thousands of years.
The document discusses analytical control strategies for biologics. It outlines identifying critical quality attributes that could impact patient safety through a risk assessment. This involves evaluating the severity of potential effects and uncertainty. A control strategy is then developed based on this risk assessment. It considers elements like raw material controls, testing, and process validation. The document provides an example of justifying a drug product shelf-life specification based on release specifications and predicted degradation over time. It also discusses setting manufacturing targets to ensure meeting product specifications as part of the overall control strategy.
Data Analysis Of An Analytical Method Transfer ToDwayne Neal
To provide the basis for a PDA task force discussion to arrive at a consensus of best industry practices for data analysis of method transfers. The discussion is also relevant to method validation activities.
Analytical method transfer involves qualifying a receiving laboratory to perform an analytical test procedure originally developed in a transferring laboratory. It ensures the receiving laboratory has the knowledge and ability to carry out the procedure as intended. There are different types of method transfers, including comparative testing, co-validation between laboratories, revalidation/partial validation, and waivers. Both the transferring and receiving laboratories have responsibilities in the method transfer process, which typically involves testing replicate samples, evaluating acceptance criteria, and documenting the transfer in a protocol.
Related Substances-Method Validation-PPT_slideBhanu Prakash N
This document provides an overview of analytical method validation. It defines validation as demonstrating a method is suitable for its intended purpose. Key validation characteristics discussed include precision, accuracy, specificity, linearity, range, detection limit, quantitation limit, ruggedness and robustness. The document describes the methodology for evaluating each characteristic, such as spiking known concentrations of analytes and establishing acceptance criteria. It emphasizes that validation confirms a method consistently produces results meeting pre-defined standards of quality.
Design controls are not an easy subject to address during and after the design of medical devices and manufacturing processes. Design controls should drive the device design process, not be an afterthought. This session focuses on treating design as a separate entity within the quality management system, user needs vs. design inputs, continuation of design controls after the transfer process, design review and more.
The nexus of chakra and crystal healing. Here you'll find all kinds of chakra jewelry, such as healing chakra necklaces, chakra bracelets, and crystal jewelry.
Stephan Krause discusses opportunities to accelerate analytical method validation for biosimilars using analytical platform technology (APT) methods. APT methods are analytical methods used for multiple products without modification that may not require full validation for each new product. Krause outlines how APT methods can be applied to product and process characterization methods as well as routine testing methods to reduce validation requirements. He also discusses the need for increased analytical method performance to address differences between biosimilars and reference products and acceptance criteria for various tiers of analytical similarity.
Wearing crystal jewelry not adds to your style, but also gives you powerful healing energies of crystals. Crystal healing has been in practice for centuries. This is because crystals contain positive energy influencing the wearer. Each particular crystal carries unique healing and metaphysical properties.
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...Stephan O. Krause, PhD
Stephan O. Krause presented on analytical method lifecycles for accelerated biological product development. He outlined typical and ideal analytical method lifecycles, highlighting opportunities to reduce steps for accelerated programs using analytical platform technology methods. Krause discussed qualification versus verification approaches for these methods, case studies on HPSEC and AUC methods, and a survey on analytical method transfers. He provided an example of revising HPSEC specifications based on manufacturing and clinical experience.
This document outlines acceptance criteria and conditions for continued process verification (CPV) of biopharmaceutical products. It discusses developing control strategies and setting non-microbiological and microbiological quality attribute limits. Typical quality attribute development over the product lifecycle is shown, including accelerated development approaches. Statistical and practical approaches for setting CPV limits are presented. Examples show how drug substance specifications and stability conditions relate to CPV limits. Response levels for out-of-specification or out-of-trend results during process validation and verification are defined based on the potential impact to product quality and process consistency.
FDA’s emphasis on quality by design began with the recognition that increased testing does not improve product quality (this has long been recognized in other industries).In order for quality to increase, it must be built into the product. To do this requires understanding how formulation and manufacturing process variables influence product quality.Quality by Design (QbD) is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.
This presentation - Part V in the series- deals with the concepts of Control strategy and PAT. This presentation was compiled from material freely available from FDA , ICH , EMEA and other free resources on the world wide web.
The document provides guidance on technology transfer between pharmaceutical manufacturing sites. It discusses that technology transfer requires a documented, planned approach with trained personnel and quality systems. A successful transfer involves the sending unit providing documentation to the receiving unit, conducting training, and jointly executing a transfer protocol. The receiving unit must demonstrate it can routinely reproduce the product or process to specifications. The guidance addresses general principles, planning, information to be transferred for active pharmaceutical ingredients and excipients, process validation, and assessing a successful transfer.
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13Stephan O. Krause, PhD
This document discusses risk-based analytical method validation and maintenance strategies. It covers topics such as risk assessment processes for analytical method validation readiness, risk-based study designs and acceptance criteria, analytical method replacement, analytical method maintenance, and analytical method transfer. The presentation provides examples and considerations for each topic.
This document provides an overview of training courses offered by QbD Academy in 2017 related to quality assurance in the pharmaceutical, medical device, and biotech industries. QbD Academy offers both on-site and online training courses on various topics including auditing, quality management systems, good manufacturing practices, validation, and regulations. The training courses range from half-day to multi-day sessions and cover the objectives, content, duration, and location for each course. Contact information is also provided for QbD Academy.
What is Validation?
Methods validation is the process of demonstrating that analytical procedures are suitable for their intended use-Guidance for Industry
Validation is a process-risk will determine the effort
High Risk:Total validation
Moderate Risk:Testing,Documentation
Low Risk:Testing the change
Validation of Analytical Methods-Key Steps
Preparation
Experimentation
Transfering Method
Documentation
Step 1- Preparation
Develop validation project plan
Define purpose/scope of method (performance criteria)
Define and verify performance of equipment
Qualify/validate materials
Qualify/train operator
Step 2- Experimentation
Perform validation experiments- may have to change either equipment or limits
Develop SOPs for executing the method in routine
Define type and frequency of system suitability tests and/or analytical quality control (AQC) checks
Define change control procedure
Document validation experiments and results
Step 3- Transferring Methods to RoutineLaboratories
Designate project owner
Develop procedure on how to use method
Develop system suitability tests (test procedure, frequency, acceptance criteria)
Define transfer tests and acceptance criteria in the routine
Train routine lab analyst in development lab
Repeat 2 critical method validation tests in routine lab
Analyze at least three samples in development and routine lab
Analyst in routine lab should give frequent feedback
Step 4- Documentation for the FDA
Validation report and supporting documentation:
Objective, scope
Methodology
Materials
Equipment
Validation data
Supporting documentation (chromatograms, spectra)
Transfer to routine protocol
Reference to SOP
Want to learn more about analytical method validation, FDA and ICH requirements and best practices to comply with them? ComplianceOnline webinars and seminars are a great training resource. Check out the following links:
ICH, FDA and USP Requirements for Method Validation
How to Validate Analytical Methods and Procedures
Validation of Analytical Methods and Procedures
Eliminate the Confusion - Analytical Method Qualification and Validation
Lifecycle Approach to Analytical Methods with QbD Elements
Analytical Instrument Qualification and System Validation
Lifecycle Approach to Analytical Methods for Drug Products
For more details:http://www.complianceonline.com/validation-of-analytical-methods-and-procedures-webinar-training-701615-prdw?channel=valppt
This training course provides an understanding of process validation requirements for pharmaceutical and biologic products. Participants will learn how to establish effective process validation systems and integrate them with other quality systems. They will also learn how to develop validation protocols and reports, as well as monitoring programs, to ensure critical process parameters remain in control. The course reviews validation needs for electronic systems and covers the FDA's process validation lifecycle approach.
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Peter Dellva
BioTechLogic's Tracy TreDenick delivered a compelling presentation discussing process validation & regulatory strategies for Fast-Track and Breakthrough Therapies at BPI West - March 20, 2018
This document provides information about an online webinar on writing effective analytical procedures. The webinar will be presented by Dr. Mark Powell, a Fellow of the Royal Society of Chemistry with over 20 years of experience as an analytical chemist. The webinar will cover best practices for writing unambiguous analytical procedures that ensure testing is performed correctly and consistently, as required by regulatory agencies. Attendees will learn how to format procedures so they are easy to follow and technically correct.
Ian brings 16 years of experience in the Biotech/Pharmaceutical Industry in Quality Assurance and Quality Control. He has extensive knowledge of all of the applicable regulatory requirements.
My last projects as an independent contractor were with SHIRE, LONZA and NOVARTIS. I conducted Product Investigations from Inoculations of Media to Manufacturing projects which included from line clearance issues to inclusions of foreign material. Also, Inspection of all product packaging to determine a non-negative product impact.
Nikam Prashant has over 7 years of experience in quality assurance for clinical trials. He has experience reviewing protocols, conducting audits of sites and departments, and ensuring compliance. Currently he works as a Scientist in Quality Assurance at Veeda Clinical Research where he reviews documents and facilitates regulatory inspections and sponsor audits. Previously he held roles with increasing responsibility at Synapse Labs, from Research Associate to Group Leader to In-Charge of Quality Assurance. He has a Master's degree in Quality Management Systems and training in good clinical practice.
This document provides a summary of Manoj Kumar Parida's professional experience and qualifications. It lists his current role as Senior Manager of Quality Control (Microbiology) at Emcure Pharmaceuticals Ltd. It then outlines his 16 years of experience in microbiology roles at various pharmaceutical companies. The document details his responsibilities in directing microbiology laboratories and ensuring compliance with regulatory standards.
This document discusses concepts of quality assurance in the pharmaceutical industry. It begins with definitions of quality assurance from WHO and ISO. It then discusses the concept of quality assurance, covering all aspects that influence drug quality. Advantages include ensuring high quality drugs while disadvantages include perfection being difficult. Quality assurance tools discussed include total quality management, quality control systems, documentation, validation, and Six Sigma methodology. Total quality management aims to continuously improve quality through participation at all levels. Quality control systems involve qualified staff and standardized procedures. Documentation and validation are important for defining systems and ensuring quality. Six Sigma uses a data-driven approach to reduce defects and improve processes.
Josephine O'Reilly is a highly experienced Quality Assurance executive with over 20 years of experience in the pharmaceutical, biopharma, medical device and diagnostics industries. She currently serves as Head of Quality EMEA and APAC at UCB, where she leads quality management initiatives and regulatory compliance efforts across multiple sites. Previously she held director-level positions at UCB Pharma responsible for product quality assurance and management of strategic contract manufacturers and suppliers.
A brief introduction of validation concept, its scope, advantage. Types of validation, stages of validation, Consideration in principle of validation. Prerequisites of validation, validation protocol, process validation, strategy of process validation of solid dosage form, validation report.
Analytical method validation.
This session will discuss all the documents used by FDA to train their inspectors to review your CAPA system, some of which you may not be familiar with.
Mr. Graham P. Alvey has over 15 years of experience in quality engineering, quality assurance, and validation roles in the pharmaceutical and medical device industries. He has a strong technical background and skills in quality systems, auditing, data analysis, and process improvement. His most recent role is as Product Quality Engineer at PerkinElmer Ltd. where he is responsible for quality of products and developing quality processes and procedures.
The document discusses improving pharmaceutical process development by:
1) Selecting drug candidates based on their "developability".
2) Choosing optimal solid forms and formulations early.
3) Taking a unit operations approach to process development to enable effective scale up and monitoring of process robustness.
Webinar validation of pharmaceutical manufacturing processesDr. Ganesh Prasad
This document outlines an upcoming webinar on current global trends in process validation presented by Dr. Ganesh Prasad. Dr. Prasad has over 25 years of experience in quality assurance and has worked for various pharmaceutical companies and regulatory agencies. The webinar will discuss regulatory perspectives on process validation from agencies like the FDA and EMA. It will also cover approaches to process design, risk assessment applications, and the stages of process validation including process performance qualification.
Similar to Design Validation Protocol and Acceptance Criteria for Chromatographic Methods to meet ICH requirements (20)
Sample ISO 13485 Quality Manual & Procedures Package ComplianceOnline
This procedure describes Management Responsibilities for the Quality Management System (QMS) at Your Company.
For more Information please visit and copy paste in browser.
http://www.complianceonline.com/iso-13485-quality-manual-procedures-package-standards-10218-prdp
Fda adverse event reporting requirements for otc drugsComplianceOnline
The document summarizes FDA requirements for reporting adverse events related to over-the-counter drugs and dietary supplements. Serious adverse events must be reported to the FDA using a Medwatch form. A serious adverse event is defined as one that results in death, is life-threatening, requires hospitalization or extended care, causes a significant disability or birth defect. The document provides guidance on when and how to submit Medwatch forms to the FDA for different product types. It encourages voluntary reporting and notes that the FDA may also contact companies directly about adverse events.
An effective enterprise risk management (ERM) program identifies, assesses, and manages risks across an organization. It establishes a framework to identify, measure, monitor, and manage risk. ERM offers a holistic approach that integrates all departments into a single risk management program aligned with business objectives. Implementing ERM involves assessing enterprise risks, articulating a risk management vision with specific capabilities and oversight, addressing high priority risks, and expanding the program to other risks. Common issues include inconsistent risk definitions, lack of risk awareness and clarity on responsibilities, and insufficient rigor in risk evaluation.
Analytical Instrument Qualification and System ValidationComplianceOnline
Analytical equipment should be qualified and computer systems should be validated to demonstrate suitability for the intended use. Electronic records must comply with FDA Part 11 and EU/PICS GMP Annex 11 requirements to ensure data integrity, security and availability. Recent EU and FDA inspection documents prove that qualification, validation and electronic laboratory are records are on target of inspectors. The large number of warning letters issued to laboratories also demonstrate that they struggle with either understanding or implementing the regulations.
This 2-day course provides the regulatory background and guides attendees through the complete equipment qualification, calibration and computer system validation processes from planning to reporting. It also helps to fully understand Part 11 and Annex 11 requirements to ensure and document integrity and other requirements for electronic records and signatures.
The course not only ensures a full understanding of the regulations and guidelines for equipment and records but also provides templates and examples to develop inspection ready documentation. Interactive exercises will be dispersed into and between the presentations. About 50% of the total time will be dedicated to practical sessions. Here attendees work in small groups on case studies and prepare the answers using prepared fill-in templates. After the course a large variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what they have learned in the course.
For More Info:
http://www.complianceonline.com/analytical-instrument-qualification-and-system-validation-seminar-training-80113SEM-prdsm?channel=slideshare
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...ComplianceOnline
This webinar will discuss the requirements for medical devices in the European Union, including the relevant directives, guidance documents, and processes for CE marking and ISO certification. It will cover topics such as the definitions and classifications of medical devices, conformity assessment, and the requirements for clinical investigations and evaluations. The webinar aims to help medical device professionals and others involved in registering devices in the EU to better understand and implement the regulations. It will be led by Robert J. Russell, an expert in global regulatory issues for medical devices.
This IFRS webinar will discuss the concepts and rule of revenue recognition and help you understand how to measure the fair value of revenue using specific IFRS guidance.
Drug Master Files (DMFs) - Understanding and Meeting Your Global Regulatory a...ComplianceOnline
This DMFs (Drug Master Files) training will discuss the current review and enforcement climate within FDA and the manner in which drug master files (DMFs) are reviewed by FDA personnel. Besides the US, the use of DMFs in the EU, Canada and Australia will also be discussed. Similarities and differences to the U.S. system will be highlighted.
The document summarizes an upcoming webinar on recalls of medical devices in the US. It discusses the FDA's perceived failures in recent years that have damaged its reputation and its new efforts to improve its image and response to issues. The webinar will cover how industry should interface with the FDA regarding recalls, potential responses to the public during a recall, analyzing product risks, communicating with the FDA, and preparing public information to protect health. It is aimed at medical device managers and others involved in quality, regulatory compliance, and public relations.
ComplianceOnline Virtual Seminar - IFRS and Effective Fraud Prevention Strate...ComplianceOnline
ComplianceOnline brings to you a full day virtual webinar session which will help you understand the IFRS basics and the risk areas and how to recognize the opportunities for fraud and develop strategies to deal with it. Whether you will be involved in preparing IFRS financial statements or analyzing those statements, come to this class to discover where the high-risk areas are and what you can do about them.
IFRS Financial Instruments – how to comply with changing requirementsComplianceOnline
This IFRS (International Financial Reporting Standards) webinar will discuss how to assign a fair value to financial instruments and how to comply with the changing rule for accounting for investment on financial statements.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Design Validation Protocol and Acceptance Criteria for Chromatographic Methods to meet ICH requirements
1. Design Validation Protocol and Acceptance Criteria for Chromatographic
Methods to meet ICH requirements
December 09, Thursday 1:00 PM EST | 4:30 PM EST
Why Should You Attend:
Analytical procedures are used to assure that the drug product meets applicable standards of identity, strength, quality
and purity during its shelf-life. The majority of analytical methods used in pharmaceutical development are HPLC analy-
ses. cGMPs require validated stability indicating methods used to monitor the drug product’s stability profiles.
This interactive 4 hrs long course will examine validation parameters for HPLC methods used in pharmaceutical laborato-
ries based on cGMP regulations and ICH guidelines. It will discuss proved forced degradation strategies to develop
stability-indicating analytical procedures. Learn effective way to write validation protocol and determine acceptance crite-
ria for validation, make documentation more manageable. This course will provide a practical and systematic approach to
validate analytical procedures.
Date: December 09, Thursday 2010
Time: 1:00 PM EST | 4:30 PM EST
Duration: 04 hrs
Instructor: Kim Huynh-Ba
Location: Your office or conference room (no need to travel!)
Areas Covered in the Seminar:
• Module I. Regulatory Requirements for Analytical Test Methods ( 40 mins)
o Drug Development Process
o cGMP requirements for analytical test methods
o Review ICH Q2 A&B guidelines for method development/validation
• Module II Development and Validation Stability Indicating Methods ( 35 mins)
o Design method specificity through forced degradation activities
o Discuss validation characteristics
• Module III. Designing Method Validation Protocols ( 35 mins)
o Establish Method Validation Protocol
o Establish Method Validation Protocol
• Module IV. Managing Validation Data for Quality and Compliance ( 55 mins)
o Design Phase-appropriate method validation
o Handling validation failure
Kim Huynh-Ba
Register Now